# Age-Stratified Conditioning Regimen Efficacy for MDS Haplo-HSCT

> **NCT07677306** · PHASE2 · RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **DRUG:** RTC conditioning regimen and Modified Bu/Cy conditioning regimen

## Key facts

- **NCT ID:** NCT07677306
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-15
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-06-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07677306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07677306, "Age-Stratified Conditioning Regimen Efficacy for MDS Haplo-HSCT". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07677306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*